Revvity, Inc. (NYSE:RVTY) Insider Tajinder S. Vohra Sells 2,153 Shares

Revvity, Inc. (NYSE:RVTY) insider Tajinder S. Vohra sold 2,153 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $122.09, for a total value of $262,859.77. Following the sale, the insider now owns 23,960 shares of the company’s stock, valued at $2,925,276.40. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Revvity Trading Down 0.4 %

Shares of RVTY stock traded down $0.51 on Wednesday, hitting $121.52. The stock had a trading volume of 391,427 shares, compared to its average volume of 820,932. The company’s 50 day moving average price is $121.58 and its 200-day moving average price is $112.15. Revvity, Inc. has a 1 year low of $79.50 and a 1 year high of $128.15. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.98. The firm has a market capitalization of $14.99 billion, a P/E ratio of 100.26, a P/E/G ratio of 2.90 and a beta of 1.05.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Monday, July 29th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. The company had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The business’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.21 earnings per share. Analysts anticipate that Revvity, Inc. will post 4.75 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 annualized dividend and a yield of 0.23%. Revvity’s dividend payout ratio is presently 23.14%.

Hedge Funds Weigh In On Revvity

Several institutional investors have recently modified their holdings of the business. Janus Henderson Group PLC grew its stake in Revvity by 3.9% during the 1st quarter. Janus Henderson Group PLC now owns 5,664,528 shares of the company’s stock worth $594,769,000 after purchasing an additional 210,100 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Revvity by 18.5% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,126,271 shares of the company’s stock worth $223,258,000 after buying an additional 332,632 shares in the last quarter. EdgePoint Investment Group Inc. purchased a new stake in shares of Revvity during the second quarter worth approximately $209,221,000. Northern Trust Corp acquired a new stake in Revvity in the fourth quarter valued at approximately $127,401,000. Finally, Dimensional Fund Advisors LP lifted its stake in Revvity by 5.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,149,122 shares of the company’s stock worth $120,506,000 after acquiring an additional 57,656 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Analyst Upgrades and Downgrades

RVTY has been the subject of a number of research reports. Wells Fargo & Company assumed coverage on shares of Revvity in a report on Tuesday, August 27th. They set an “equal weight” rating and a $130.00 target price for the company. Bank of America raised their target price on Revvity from $118.00 to $127.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 30th. Leerink Partners started coverage on shares of Revvity in a research report on Monday, July 8th. They set an “outperform” rating and a $125.00 price target on the stock. Barclays raised their price objective on shares of Revvity from $115.00 to $125.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Finally, Leerink Partnrs upgraded shares of Revvity to a “strong-buy” rating in a report on Monday, July 8th. Eight research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $125.53.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.